(Press-News.org) Key takeaways
New research shows that treatment of heart failure patients with a type of anti-obesity medication reduces the environmental footprint of healthcare, as well as improving clinical outcomes.
People being treated for heart failure with GLP-1 receptor antagonists used 0.25 kg CO₂-equivalent less per person annually, compared to patients with heart failure taking a placebo. When this saving is scaled to the millions of people eligible for the treatment, the findings suggest that 2 billion kilograms of CO₂-equivalent could be saved annually.
The study is one of the first to quantify the environmental co-benefits of pharmacologic treatment. The authors hope that studies like this will empower policy makers, clinicians and patients to consider environmental outcomes alongside clinical outcomes in the future.
Madrid, Spain - 27 August, 2025 : New research has found that the use of GLP-1 receptor agonists*, a class of medications commonly prescribed for patients with obesity and diabetes, reduces the environmental footprint of healthcare and clinical outcomes when used to treat heart failure.
Treatment of heart failure patients with these therapies led to fewer hospitalizations and lower calorie intake, which together translated into decreased greenhouse gas emissions, less medical waste, and reduced water usage.
The study is one of the first to quantify the environmental co-benefits of pharmacologic treatment. The findings are being presented today at the 2025 European Society of Cardiology Congress in Madrid, Spain.
The healthcare sector is responsible for nearly 5% of greenhouse gas emissions globally (1), highlighting the need for interventions to reduce the environmental footprint of clinical care.
Patient level meta-analysis of four randomised controlled trials, SELECT, FLOW, STEP HFpEF, and STEPHFpEF DM, was conducted. All the trials involved patients with a type of heart failure, called heart failure with preserved ejection fraction, who had been treated with GLP-1 receptor agonists or a placebo. Estimates of mean inpatient days, ICU admissions, emergency department and ambulatory visits per event of heart failure, and related greenhouse gas emissions were obtained from previously published literature.
A total of 54 worsening heart failure events were reported among 1,914 patients receiving GLP1-receptor antagonist treatment, compared to 86 events among 1,829 patients receiving placebo.
Those receiving the treatment were estimated to have 9.45 kg CO₂-equivalent emissions per patient per year, compared to 9.70 kg CO₂-equivalent emissions per patient per year among placebo users. The differences were predominantly driven by emissions arising from inpatient stays and outpatient visits due to worsening heart failure events.
The study was led by Dr.Sarju Ganatra, Director of Sustainability and Vice Chair of Research at Lahey Hospital & Medical Center in the US and the President of Sustain Health Solutions, a non-profit organization that helps healthcare organizations integrate sustainability in care delivery. He explained, “The magnitude of the potential environmental emission savings found in our analysis was striking.”
“0.25 kg of CO2-equivalent per person saved annually from reduced hospitalizations might sound small. However, when this figure is scaled up to the millions of patients eligible for these therapies, it adds up to over 2 billion kilograms of CO2-equivalent saved. Similar-scale reductions were observed in waste generation and water use. This research highlights how even modest incremental individual gains can result in significant collective impact,” Dr Ganatra continued.
2 billion kg of CO2 is approximately equivalent to 20,000 full capacity Boeing 747 long-haul flights, or city-wide emissions from Brussels over 3 months. Around 30 million trees grown over 10 years would be needed to offset 2 billion kg of CO2.
The analysis also showed that those taking the GLP1-receptor antagonist treatment had approximately 695.33 kg CO2-equivalent lower emissions per patient per year due to a reduction in daily calorie consumption compared to placebo.
“By combining clinical trial data with environmental life cycle assessment metrics, we offer a new lens to evaluate the full impact of prescribing decisions. We also show that it is possible for medical treatments to deliver dual benefits—better health for patients and a healthier planet,” Dr Ganatra added. “We hope that in the future, policymakers will integrate sustainability metrics into health technology assessments, drug coverage decisions, and procurement frameworks.”
Each worsening heart failure event was assumed to involve one inpatient admission and a round trip to the hospital. Greenhouse gas emissions associated with the production and use of a GLP1 receptor agonist were obtained from a leading pharmaceutical drug manufacturer.
The study used modelling data from prior trials and established environmental life cycle assessment emissions data sets, rather than direct measurements. It could not take into account patient-level variability such as behavioural differences, and the research used mean values for hospital-related emissions.
“The next step for this research is to validate our modelling with real-world emissions data and clinical outcomes. In the future, we hope that environmental impact will be integrated into clinical trial designs, drug regulatory processes, and formulary decisions to ensure health systems align with planetary health goals,” Dr Ganatra concluded.
The findings from this study also support previous research that found that treatment of patients with GLP-1 receptor agonists reduced hospital visits for patients with heart failure with preserved ejection fraction.
ENDS
Notes to editor
This press release accompanies an abstract at ESC Congress 2025.
It does not necessarily reflect the opinion of the European Society of Cardiology.
Funding: N/A
Disclosures: None provided
References and notes:
*Glucagonlike peptide 1 (GLP-1) receptor agonists are medicines that mimic the action of a hormone, called GLP-1, that is released by the stomach when food is eaten. These medicines have a number of actions including reducing appetite, slowing down the digestion of food, reducing the sugar that the liver makes, and helping the body to make more insulin.
https://global.noharm.org/sites/default/files/documents-files/5961/HealthCaresClimateFootprint_092319.pdf
The abstract «Environmental impact of novel anti-obesity medications on healthcare-related greenhouse gas emissions in patients with heart failure with preserved ejection fraction » will be presented at the session Perspectives in public health and cardiovascular diseases which takes place on 31 August from 2:15 to 3:00 pm CEST at Ex-change Circle 4 - Research Gateway
ESC Press Office
Tel: +33 661401884
Email: press@escardio.org
The hashtag for ESC Congress 2025 is #ESCCongress
Follow us on LinkedIn @European Society of Cardiology News
Journalists are invited to become accredited and register here.
Check out the ESC Media and Embargo Policy.
About ESC Congress 2025
It is the world’s largest gathering of cardiovascular professionals, disseminating ground-breaking science both onsite in Madrid and online – from 29 August to 1 September 2025. Explore the scientific programme. More information is available from the ESC Press Office at press@escardio.org.
About the European Society of Cardiology
The ESC brings together healthcare professionals from more than 150 countries, working to advance cardiovascular medicine and help people to live longer, healthier lives.
END
Treating heart failure patients with anti-obesity medication reduces greenhouse gas emissions and improves clinical outcomes
2025-08-27
ELSE PRESS RELEASES FROM THIS DATE:
Cardiac arrest in space: New research shows that automatic chest compressions are more effective for CPR when both rescuer and patient are floating in microgravity
2025-08-27
Key take-aways
New research has found that a type of automatic chest compression is more effective to carry out CPR in space than the ‘handstand method’ that is currently recommended in emergency protocols for spaceflight. Treating cardiac arrest during spaceflight is challenging because both the rescuer and the patient are floating due to microgravity, which makes doing chest compressions challenging.
The research was conducted in a ‘flying laboratory’ in a modified A310 aircraft at the CNES (French ...
Older age and low fitness levels are associated with heartbeat abnormalities that increase future cardiovascular risk
2025-08-27
Key take-aways
New research finds that low fitness levels and older age are strong and independent risk factors for heartbeat irregularities, or arrhythmias*, in healthy adults. These arrhythmias were previously thought to be harmless, but are now considered to be an indicator of future cardiovascular risk (1,2)
The results support the introduction of age-based arrhythmia screening in over 50s, to allow for early intervention before symptoms arise to alter the trajectory of disease
There was a particularly strong association between lower aerobic fitness and risk of frequent and complex atrial arrythmias, ...
‘Built for cutting flesh, not resisting acidity’: sharks may be losing deadly teeth to ocean acidification
2025-08-27
Sharks can famously replace their teeth, with new ones always growing as they’re using up the current set. As sharks rely on their teeth to catch prey, this is vital to the survival of one of the oceans’ top predators.
But the ability to regrow teeth might not be enough to ensure they can withstand the pressures of a warming world where oceans are getting more acidic, new research has found. Researchers in Germany examined sharks’ teeth under different ocean acidification scenarios and showed that more acidic oceans lead to more brittle and weaker teeth.
“Shark teeth, despite being composed of highly mineralized phosphates, are still vulnerable to corrosion under ...
Study reveals beneficial effects of diet and exercise on alcohol-related adverse liver health
2025-08-27
Amsterdam, August 27, 2025 – A novel study investigating how physical activity and diet quality interact with different levels and patterns of alcohol consumption shows that healthy eating and increased levels of physical activity significantly lower the risk of alcohol-attributable liver-related mortality. The findings from this comprehensive new study in the Journal of Hepatology, published by Elsevier, use data from a large multi-ethnic US cohort and highlight the importance of considering other lifestyle behaviors when estimating the risk of death from alcohol-related liver disease at a population level.
In the US, more than half (53%) of adults over 18 years of age regularly ...
Making the weight in four years
2025-08-27
Kyoto, Japan -- Periodical cicadas have one of the strangest life cycles in the animal kingdom. The 17-year cicadas spend 99.5% of their lives underground in an undeveloped nymph state, which is the longest strictly regulated juvenile period among insects.
Then in the spring of their 17th year, they simultaneously emerge and the males scream above ground for their four to six week-long adult life. Exactly how these insects are able to control when they mature and emerge has remained a mystery.
The long life cycle of periodical cicadas makes rearing nymphs for study extremely difficult. Recently, however, a collaborative team of researchers from both Japan and the ...
AI review unveils new strategies for fixing missing traffic data in smart cities
2025-08-27
A new review published in Artificial Intelligence and Autonomous Systems（AIAS） highlights how artificial intelligence can tackle the pervasive problem of missing traffic data in intelligent transportation systems. The study categorizes and compares leading data imputation methods, offering a clear roadmap for researchers and city planners to improve traffic management and smart city operations.
As cities worldwide deploy more sensors and intelligent systems to manage traffic, a hidden problem is undermining their efforts: missing data. Sensor failures, communication dropouts, and harsh environmental conditions often lead to ...
Scientists discovered hopfion crystals – which are flying in spacetime
2025-08-27
An internationally joint research group between Singapore and Japan has unveiled a blueprint for arranging exotic, knot-like patterns of light into repeatable crystals that extend across both space and time. The work lays out how to build and control “hopfion” lattices using structured beams at two different colors, pointing to future systems for dense, robust information processing in photonics.
Hopfions are three-dimensional topological textures whose internal “spin” patterns weave into closed, interlinked loops. They have been observed ...
For bees, diet isn’t one-size-fits-all
2025-08-27
Move over gym rats. Bumble bees are now the true masters of macros.
In the first long-term, community-level field study of wild bumble bee nutrition, a team of ecologists led by Northwestern University and the Chicago Botanic Garden discovered that wild bees aren’t just flitting from flower to flower, collecting pollen at random. Instead, they are strategically targeting flowers that enable them to carefully balance their protein, fat and carbs.
Focusing on pollen consumption, the study revealed that coexisting bee species occupy two distinct nutrient niches. Larger bodied bees with longer tongues prefer pollen that’s ...
How a malaria-fighting breakthrough provides lasting protection
2025-08-27
A relatively new class of insecticide that can be disseminated on something the size of a sheet of paper offers protection for up to a year against mosquitoes that spread malaria, as well as dengue, West Nile, yellow fever, and Zika, UC San Francisco researchers have found.
In a systematic review of more than 25 years of data on some 1.7 million mosquitoes, researchers concluded that this form of repellent — called a “spatial emanator” because it distributes chemicals through the air — can prevent more than ...
Cognitive Behavioural therapy can alter brain structure and boost grey matter volume, study shows
2025-08-27
Psychotherapy leads to measurable changes in brain structure. Researchers at Martin Luther University Halle-Wittenberg (MLU) and the University of Münster have demonstrated this for the first time in a study in “Translational Psychiatry” by using cognitive behavioural therapy. The team analysed the brains of 30 patients suffering from acute depression. After therapy, most of them showed changes in areas responsible for processing emotions. The observed effects are similar to those already known from studies on medication.
Around ...